Metagenomic Sequencing Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Metagenomic Sequencing Market Between 2025 And 2029?

The metagenomic sequencing market has experienced swift expansion recently. It is anticipated to increase from $2.13 billion in 2024 to $2.5 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.2%. The growth observed historically can be attributed to several factors such as greater government engagement, the rising count of metagenome sequencing research initiatives, the expanding application of metagenomics in genomics and diagnostics research, the availability of research funds, and the evolution of NGS data analysis instruments.

The metagenomic sequencing market is anticipated to experience swift expansion over the coming years. By 2029, its valuation is projected to reach $4.54 billion, demonstrating a compound annual growth rate (CAGR) of 16.1%. This projected growth is driven by factors such as declining computational expenses, an intensified focus on identifying new biomolecules of significance, the wider integration of high-throughput sequencing technologies, the necessity for personalized medical treatments and disease identification, and a rise in the occurrence of infectious diseases. Key developments expected during this timeframe encompass pioneering technologies, the application of sophisticated genomic methods within metagenomics, increased investment in research and development, progress in sequencing techniques, and the use of big data for NGS data analysis.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

Which Major Market Drivers Are Shaping The Future Of The Metagenomic Sequencing Market?

The increasing occurrence of infectious diseases is anticipated to propel the expansion of the metagenomic sequencing market. These diseases are conditions resulting from disease-causing microorganisms like bacteria, viruses, parasites, or fungi, capable of transmitting between individuals either directly or indirectly. A rise in conditions that compromise the immune system, including HIV/AIDS, cancer therapies, and autoimmune issues, renders people more vulnerable to contracting infectious diseases. Metagenomic sequencing presents an effective and adaptable method for examining infectious diseases, offering critical understanding of pathogen variety, how diseases spread, resistance to antimicrobials, and monitoring of outbreaks. For example, a report from the Government of Canada, a federal authority in Canada, stated in January 2023 that 135 rabies samples were submitted in October 2022 and 159 rabies samples in November 2022. Additionally, in March 2023, the Centers for Disease Control and Prevention, a US government agency, reported a 5.9% increase in tuberculosis (TB) cases in the US, rising from 7,874 cases in 2021 to 8,331 cases in 2022. Consequently, the increased occurrence of infectious diseases is fueling the expansion of the metagenomic sequencing market.

How Is The Metagenomic Sequencing Market Classified Into Different Segments?

The metagenomic sequencingmarket covered in this report is segmented –

1) By Product And Service: Reagents And Consumables; Instruments; Sequencing Services; Analysis And Data Interpretation Solutions

2) By Technology: 16S Rrna Sequencing; Shotgun Metagenomic Sequencing; Whole-Genome Sequencing And De Novo Assembly; Metatranscriptomics

3) By Application: Clinical Diagnostic; Environmental Remediation; Gut Microbe Characterization; Drug Discovery; Biofuel; Agriculture; Other Applications

Subsegments:

1) By Reagents And Consumables: DNA Or RNA Extraction Kits; Library Preparation Kits; Sequencing Kits; PCR And qPCR Reagents; Other Consumables (Buffers, Probes)

2) By Instruments: Next-Generation Sequencers (NGS); Third-Party Sequencers; Microarrays; Real-Time PCR Instruments

3) By Sequencing Services: Whole Genome Sequencing (WGS); 16S rRNA Sequencing; Shotgun Metagenomic Sequencing; Amplicon Sequencing; Metatranscriptomic Sequencing

4) By Analysis And Data Interpretation Solutions: Bioinformatics Software; Cloud-Based Data Analysis Services; Data Storage Solutions; Custom Analysis Tools; Data Interpretation Platforms

What Trends Are Expected To Drive The Metagenomic Sequencing Market?

Leading firms within the metagenomic sequencing market are concentrating their efforts on enhancing sequencing services to boost accuracy, increase throughput, and reduce costs. These services encompass advanced genomic technologies designed to sequence extended DNA fragments, thereby offering a more thorough understanding of genetic structures than conventional short-read approaches. As an illustration, in April 2024, Clinical Microbiomics A/S, a biotechnology company headquartered in Denmark, introduced sophisticated long-read sequencing services. These offerings, which include 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics, deliver unmatched resolution and quality for microbial analysis, allowing for in-depth insights into microbial communities and supporting the generation of high-quality metagenome-assembled genomes.

Who Are The Prominent Global Companies Shaping The Metagenomic Sequencing Market?

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Metagenomic Sequencing Market?

North America was the largest region in the metagenomic sequencing market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Metagenomic Sequencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16117&type=smp

Browse Through More Reports Similar to the Global Metagenomic Sequencing Market 2025, By The Business Research Company

Metagenomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metagenomics-global-market-report

Clinical Oncology Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Next Generation Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795